Literature DB >> 11919131

Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers.

Samy I McFarlane1, Scott J Jacober, Nathaniel Winer, Jasjeet Kaur, Jonathan P Castro, MaryLou A Wui, Agnes Gliwa, Hans Von Gizycki, James R Sowers.   

Abstract

OBJECTIVE: There are national mandates to reduce blood pressure (BP) to <130/85 mmHg, LDL cholesterol to <100 mg/dl, and HbA(1c) to <7% and to institute aspirin therapy in patients with diabetes. The objective of this study was to determine the proportion of patients in urban institutions with diabetes and hypertension who meet these treatment goals. RESEARCH DESIGN AND METHODS: Using American Diabetes Association (ADA) guidelines, we evaluated the control of cardiovascular disease (CVD) risk factors in 1,372 patients receiving medical care at two major urban medical centers in Brooklyn and Detroit. Information was extracted from charts of outpatient clinics.
RESULTS: Of 1,372 active clinic patients with diabetes and hypertension, 1,247 (90.9%) had type 2 diabetes, and 26.7% met the target blood pressure of 130/85 mmHg. A total of 35.5% met the goal LDL cholesterol level of <100 mg/dl, 26.7% had an HbA(1c) <7%, and 45.6% were on antiplatelet therapy. Only 3.2% of patients met the combined ADA goal for BP, LDL cholesterol, and HbA(1c).
CONCLUSIONS: Optimal control of CVD risk factors in adults with diabetes was achieved only in a minority of patients. Results reflect the inherent difficulties in achieving these complex guidelines in our present health care systems.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11919131     DOI: 10.2337/diacare.25.4.718

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  50 in total

1.  Adding low-dose spironolactone to multidrug regimens for resistant hypertension.

Authors:  Kathleen H Berecek; Amal Farag; Gul Bahtiyar; Jeffery Rothman; Sammy I McFarlane
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

Review 2.  Provider and systems factors in diabetes quality of care.

Authors:  Kimia Ghaznavi; Shaista Malik
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

3.  Simultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients.

Authors:  George L Jackson; David Edelman; Morris Weinberger
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

4.  Clinical trials report. Hypertensive diabetic patients: INVESTing in the prevention of cardiovascular disease.

Authors:  Surender Arora; John Nicasio; Samy I McFarlane
Journal:  Curr Hypertens Rep       Date:  2005-06       Impact factor: 5.369

5.  The DREAM trial and the prospect of diabetes prevention.

Authors:  Samy I McFarlane; Tanja Rundek; John Nicasio; Mrunalini Deshmukh; James R Sowers
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

6.  Laparoscopic gastric bypass in patients 60 years and older: early postoperative morbidity and resolution of comorbidities.

Authors:  Alan C Wittgrove; Tracy Martinez
Journal:  Obes Surg       Date:  2009-08-25       Impact factor: 4.129

7.  Nurse-led behavioral management of diabetes and hypertension in community practices: a randomized trial.

Authors:  David Edelman; Rowena J Dolor; Cynthia J Coffman; Katherine C Pereira; Bradi B Granger; Jennifer H Lindquist; Alice M Neary; Amy J Harris; Hayden B Bosworth
Journal:  J Gen Intern Med       Date:  2015-01-08       Impact factor: 5.128

Review 8.  Management of diabetic and hypertensive cardiovascular disease.

Authors:  Edward D Frohlich; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

9.  Telemedicine cardiovascular risk reduction in veterans.

Authors:  S Dee Melnyk; Leah L Zullig; Felicia McCant; Susanne Danus; Eugene Oddone; Lori Bastian; Maren Olsen; Karen M Stechuchak; David Edelman; Susan Rakley; Miriam Morey; Hayden B Bosworth
Journal:  Am Heart J       Date:  2013-02-28       Impact factor: 4.749

Review 10.  Antidiabetic medications and weight gain: implications for the practicing physician.

Authors:  Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.